期刊文献+

肺栓塞严重指数在非高危急性肺血栓栓塞症中的临床价值 被引量:3

Clinical value of pulmonary embolism severity index in non high-risk acute pulmonary thromboembolism
原文传递
导出
摘要 目的 对接受序贯抗凝治疗的非高危急性肺血栓栓塞症患者进行肺栓塞严重指数(PESI)评分,评价PESI评分在这一类患者中的临床价值.方法 按照PESI评分的不同将接受序贯抗凝治疗的非高危急性肺血栓栓塞症患者分为高评分组和低评分组.比较两组不良事件的发生率和疗效.结果 高评分组患者82例,低评分组患者76例.高评分组不良事件发生率为23.2%(19/82),低评分组为7.9%(6/76),两组比较差异有统计学意义(P=0.009),高评分组不良风险序贯抗凝治疗30 d累积风险也显著高于低评分组,差异有统计学意义(P<0.05).PESI评分预测不良事件发生的敏感度为76.0%,特异度为52.6%,阳性预测值为64.6%,阴性预测值为65.9%.高评分组的病死率为9.8%(8/82),低评分组为1.3%(1/76),两组比较差异有统计学意义(P=0.022).序贯抗凝治疗30 d后高评分组和低评分组患者肺动脉收缩压分别为(39.4±8.1)、(27.2±5.5) mm Hg(1 mm Hg=0.133 kPa),右室内径分别为(33.0±7.8)、(21.7±4.6) mm,动脉血氧分压分别为(75.15±12.41)、(86.36±9.22) mm Hg,两组比较差异有统计学意义(P=0.034、0.021、0.016).结论 PESI评分可有效预测接受序贯抗凝治疗的非高危急性肺血栓栓塞症患者的短期疗效和预后.这一类患者中至少有一部分可能需要序贯抗凝以外的治疗. Objective To evaluate the clinical value of pulmonary embolism severity index (PESI) in non high-risk acute pulmonary thromboembolism (APTE) patients treated with sequential anticoagulation.Methods Non high-risk APTE patients treated with sequential anticoagulation were divided into two groups according to PESI:high-value group and low-value group.Prognosis and treatment response was compared between two groups.Results There were 82 cases in high-value group,and 76 cases in low-value group.The rate of adverse events in high-value group was significantly higher than that in low-value group [23.2%(19/82) vs.7.9% (6/76)] (x2 =5.0698,P =0.009),and 30 days cumulative hazard was also significantly higher than that in low-value group (P 〈 0.05).The sensitivity of predicting adverse events by PESI was 76.0%,specificity was 52.6%,positive predicting value was 64.6%,and negative predicting value was 65.9%.The mortality in high-value group was significantly higher than that in low-value group [9.8%(8/82) vs.1.3% (1/76)] (P =0.022).After 30 days of anticoagulation,the pulmonary artery systolic pressure,internal diameter of right ventricle in high-value group was significantly higher than that in low-value group [(39.4 ± 8.1) mm Hg (1 mm Hg =0.133 kPa) vs.(27.2 ± 5.5) mm Hg,(33.0 ± 7.8) mm vs.(21.7 ± 4.6) mm] (P =0.034,0.021),and arterial oxygen partial pressure was significantly lower than that in low-value group[(75.15 ± 12.41) mm Hg vs.(86.36 ± 9.22) mm Hg](P=0.016).Conclusions PESI can effectively predict short-term prognosis of non high-risk APTE patients treated with sequential anticoagulation.At least some of these patients might need treatment other than sequential anticoagulation.
出处 《中国医师进修杂志》 2013年第31期18-21,共4页 Chinese Journal of Postgraduates of Medicine
关键词 肺栓塞 预后 肺栓塞严重指数 Pulmonary embolism Anticoagulation Pulmonary embolism severity index
  • 相关文献

参考文献10

  • 1急性肺血栓栓塞症诊断治疗中国专家共识[J].中华内科杂志,2010,49(1):74-81. 被引量:398
  • 2Torbicki A,Perrier A,Konstantinides S,et al.Guidelines on the diagnosis and management of acute pulmonary embolism:the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).Eur Heart J,2008,29(18):2276-2315.
  • 3Labyk A,Ciurzy (n) ski M,Jankowski K,et al.Acute pulmonary embolism:analysis of consecutive 353 patients hospitalised in a single centre.A 3-year experience.Kardiol Pol,2012,70 (1):15-22.
  • 4Soares TH,de Bastos M,de Carvalho BV,et al.Prognostic value of computed tomographic pulmonary angiography and the pulmonary embolism severity index in patients with acute pulmonary embolism.Blood Coagul Fibrinolysis,2013,24(1):64-70.
  • 5Penaloza A,Roy PM,Kline J.Risk stratification and treatment strategy of pulmonary embolism.Curr Opin Crit Care,2012,18(4):318-325.
  • 6肺血栓栓塞症的诊断与治疗指南(草案)[J].中华结核和呼吸杂志,2001,24(5):259-264. 被引量:1838
  • 7Sam A,S á nchez D,G ó mez V,et al.The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism.Eur Respir J,2011,37(4):762-766.
  • 8Fasullo S,Scalzo S,Maringhini G,et al.Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction:comparison of thrombolysis with heparin.Am J Med Sci,2011,341 (1):33-39.
  • 9Khorana AA.Cancer and coagulation.Am J Hematol,2012,87Suppl 1:S82-87.
  • 10Thaler J,Ay C,Pabinger I.Venous thromboembolism in cancer patients-risk scores and recent randomised controlled trials.Thromb Haemost,2012,108(6):1042-1048.

二级参考文献44

  • 1荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 2邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 3Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
  • 4Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
  • 5PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
  • 6Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
  • 7Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
  • 8Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
  • 9Dalla-Volta S, Palla A, Santolicandro A, et al. PALMS 2: aheplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520-526.
  • 10Levine M, Hirsh J, Weitz J, et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest, 1990, 98: 1473-1479.

共引文献2189

同被引文献27

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部